Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermis-specific serine protease-like protein pseudogene (None commonly used; sometimes abbreviated as ESSPL, but this is not standardized)
- Target
- None commonly used; sometimes abbreviated as ESSPL, but this is not standardized
- Molecular classification
- Pseudogene, Long non-coding RNA (if transcribed)
01
Overview
ENSG00000250350 encodes the epidermis-specific serine protease-like protein pseudogene, a non-functional genomic element annotated as a pseudogene. Pseudogenes arise from functional genes that accumulate mutations, rendering them incapable of encoding a functional protein[2][3]. While the vast majority of pseudogenes do not have protein-coding or canonical molecular roles, some have emerging functions at the RNA level, such as acting as microRNA decoys, antisense regulators, or contributors to non-coding RNA signaling networks. There is no evidence that this particular pseudogene is implicated in disease pathogenesis, interacts with drugs, or serves as a biomarker in current clinical or research practice[1][2][3][4][9]. Its principal biological characterization is that of a non-coding genomic element with high homology to serine proteases but without protein-coding function[1][2].
- Other names
- ESSPL pseudogeneEnsembl identifier: ENSG00000250350Previous: GC04M152200
02
Mechanism of action
None applicable for drugs, as this is not a functional protein target
03
Biological functions
No canonical protein function (as is the case for pseudogenes)Possible regulatory RNA function (if transcribed): may act via microRNA decoy, antisense regulation, or competing endogenous RNA—as shown by several pseudogenes, primarily in other well-studied casesIf transcribed, may contribute to non-coding RNA networks in the cell
04
Disease associations
None established for this specific pseudogenePseudogenes generally have emerging roles in cancer, gene regulation, and potentially other diseases via regulatory RNA functions—but specific evidence for ENSG00000250350 is lacking
Beyond the preview
Go deeper on Epidermis-specific serine protease-like protein pseudogene (None commonly used; sometimes abbreviated as ESSPL, but this is not standardized).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epidermis-specific serine protease-like protein pseudogene (None commonly used; sometimes abbreviated as ESSPL, but this is not standardized).